nivolumab,ipilimumab
bms
['nivolumab', 'check,mate,227', 'lung', 'ipilimumab', 'nivo', 'bmsnews', 'bms']
join presenting results from checkmate 227: five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non small cell #lungcancer #asco22 hall a starting 8 am
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements